CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection
about
Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus MacaquesHIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus VaccineDynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection.Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells.Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.Development of targeted adjuvants for HIV-1 vaccinesHIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
P2860
Q28830298-AF5BE23A-4FCE-4166-843F-279C51B786E0Q35728947-213DFE0F-A268-41C9-9E95-A181AB10F380Q35914306-294AEF74-FF8A-4895-8DDA-DDCA4AFBEAB7Q36260414-3C670699-78C5-49D1-BCBA-6F1499FD2C23Q36708266-42057B21-D9BD-44A8-9EBD-58DC44B13F21Q37682298-C3FAA6C8-DCCE-4168-8B28-F336ED875E58Q39535061-F2A4E08C-48A3-46C7-871C-E12210BB66B1Q40071705-A8CBE55D-6924-4A42-8840-BEFA36C55C8BQ41277922-B68F003C-94B7-41AA-B87B-0439F7E3EF08Q41918753-B12BEF80-E030-4C09-8FED-6C17B2E9E945Q47276928-A57C1E91-7CB3-4516-BB6C-52E3EE1AD9C8Q56517308-C87D0BC0-FF1D-4678-A270-DE16FF86A4D1
P2860
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@ast
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@en
type
label
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@ast
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@en
prefLabel
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@ast
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@en
P2093
P2860
P356
P1433
P1476
CD40L-adjuvanted DNA/modified ...... esistant mucosal SIV infection
@en
P2093
Blandine Victor
Celia C LaBranche
Francois Villinger
Georgia D Tomaras
Jung Joo Hong
Pamela A Kozlowski
Rahul Basu
Rama Rao Amara
Sailaja Gangadhara
Shanmugalakshmi Sadagopal
P2860
P304
P356
10.1128/JVI.03527-14
P407
P577
2015-02-04T00:00:00Z